Qualitative and quantitative insights were obtained by interviewing supply-side and demand-side stakeholders during the primary research process. Supply-side sources consist of CEOs, VPs of Product Development, regulatory affairs chiefs, and commercial directors from oral care OEMs, pharmaceutical companies, and dental product manufacturers. Practiced dentists, pediatric dental specialists, dental hygienists, school health program coordinators, procurement leaders from dental service organizations (DSOs), community health center administrators, and pharmacy retail buyers comprised demand-side sources. The market segmentation was validated through primary research, which also confirmed the product pipeline timelines and gathered insights on clinical adoption patterns, pricing strategies, reimbursement dynamics, and fluoride treatment protocol variations across regions. The market segmentation was conducted across procedure types (professional vs. self-applied), delivery methods (gels, varnishes, foams, rinses), target populations (children/adolescents, adults, pregnant women), and application settings (dental offices, schools, community health centers).
Primary Respondent Breakdown:
By Designation: C-level Primaries (32%), Director Level (31%), Others (37%)
By Region: North America (38%), Europe (25%), Asia-Pacific (28%), Rest of World (9%)
Global market valuation was derived through revenue mapping and procedure volume analysis. The methodology included:
Identification of 40+ key manufacturers across North America, Europe, Asia-Pacific, and Latin America
Product mapping across professional fluoride applications, self-applied fluoride treatments, and delivery formats including gels, varnishes, foams, and rinses
Analysis of reported and modeled annual revenues specific to dental fluoride treatment portfolios
Coverage of manufacturers representing 75-80% of global market share in 2024
Extrapolation using bottom-up (procedure volume × ASP by country/setting) and top-down (manufacturer revenue validation) approaches to derive segment-specific valuations across procedure types, delivery methods, target populations, and application settings